LINCOLN PROTEINS LIMITEDActive

We aim to present a balanced and comprehensive review of the development and performance of our business during the year and its position at the year end. Our review is consistent with the size and nature of our business and is written in the context of the risks and uncertainties we face. PRINCIPAL ACTIVITY Lincoln Proteins Limited is a wholly owned subsidiary of Lincoln Protein Holdings Ltd. Its revenue is derived from the collection of material and the sale of tallow and meat and bonemeal. BUSINESS REVIEW The company has reported an increase in revenue to £5,836,380 (2023 - £5,995,984). Operating profit amounted to £1,290,036 (2023 - £1,280,149). The results reflect a reduction in volumes as these are processed through the group's other rendering facilities, and a corresponding reduction in the associated costs. During the period shareholder's funds increased to £25,639,128 (2023 - £24,541,967). Capital expenditure during the period was £467,184 reflecting ongoing investment in increasing capacity. The company's key performance indicators are energy and transport costs relative to throughput. The company's aim is to further build its supply base and improve performance through increased throughput and operational performance. RISK MANAGEMENT POLICIES The company faces a number of risks and the directors continue to mitigate these as far as possible. A summary of the key risks are as follows. Interest rate risk The company's exposure to market risk for the changes in intere

As described in the company's latest filed accounts.